 new potent verapamil deriv multidrug resist human renal carcinoma cell transgen mice human gene multidrug resist human renal cell carcinoma express gene broad spectrum cross resist mani natur product chemotherapeut agent resist chemosensit function gene product p-glycoprotein develop new agent side effect potenc resist high prioriti research drug resist new verapamil deriv primari human renal cell carcinoma vitro mdr-transgen mice model mice human gene bone marrow cell measur white blood count simpl rapid reliabl system potenc mdr-revers agent vivo drug effect multidrug resist primari cultur human renal cell carcinoma combin vinblastin chemotherapi extent doxorubicin daunomycin chemotherapi vivo data agent low toxic high concentr effect low achiev concentr drug r-verapamil result new drug attract candid clinic trial